SEROQUEL SETTLEMENT $68.5M

March 11, 2011

WASHINGTON - AstraZeneca will pay $68.5 million in a multistate settlement over allegations that it promoted its blockbuster psychiatric drug, Seroquel, for insomnia, Alzheimer's, and other unapproved uses.



Full Story Below

Rapid Response
Free Case Evaluation


The Help You Need,
When You Need it Most

Please Type The Number You See Below

2127

More from Settlement News Directory

Claim Your Attorney Profile
Lawyer Central Legal Sites
  Injury     Bankruptcy     Dangerous Products     Family     Real Estate     Estate Planning     Immigration     Disability     Employment     Toxic Torts     Criminal     Litigation  

Find us on Facebook! Follow us on Twitter!

Lawyer State Directories
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | Florida | Georgia | Hawaii | Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico | New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee | Texas | Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin | Wyoming |
May 27, 2012
Terms & Conditions
Site Map


Follow @lawyercentral